Virginia Retirement Systems’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-13,200
Closed -$110K 973
2025
Q4
$110K Hold
13,200
﹤0.01% 938
2025
Q3
$192K Hold
13,200
﹤0.01% 902
2025
Q2
$149K Hold
13,200
﹤0.01% 913
2025
Q1
$75.2K Buy
+13,200
New +$134K ﹤0.01% 1006

Other funds holding DNA

Virginia Retirement Systems's DNA Position: Q1 2026 in Review

Virginia Retirement Systems sold out of Ginkgo Bioworks (DNA) in Q1 2026, closing a stake of 13,200 shares — an estimated $110K sold.

Virginia Retirement Systems first reported a position in DNA in Q1 2025 and held it in 4 quarters. The position peaked at $192K in Q3 2025. 175 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

  • Virginia Retirement Systems reported no remaining Ginkgo Bioworks position as of Q1 2026 after selling out during the quarter.
  • Virginia Retirement Systems sold 13,200 Ginkgo Bioworks shares in Q1 2026, an estimated $110K.
  • Virginia Retirement Systems first reported a position in Ginkgo Bioworks in Q1 2025 and held it in 4 quarters.
  • Virginia Retirement Systems's Ginkgo Bioworks position peaked at $192K in Q3 2025.
  • 175 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on Virginia Retirement Systems's 13F filing for Q1 2026, filed 25 Aug 2026.